Literature DB >> 19809558

In reply: Different role of secondary cytoreductive surgery by surgeon's experience and hospital facility.

Myong Cheol Lim1, Jaeman Bae, Sang-Yoon Park.   

Abstract

Year:  2009        PMID： 19809558      PMCID： PMC2757569          DOI： 10.3802/jgo.2009.20.3.199

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN： 2005-0380            Impact factor:   4.401


× No keyword cloud information.
  3 in total

1.  Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.

Authors:  Dennis S Chi; Kristina McCaughty; John P Diaz; Jae Huh; Sarah Schwabenbauer; Amanda J Hummer; Ennapadam S Venkatraman; Carol Aghajanian; Yukio Sonoda; Nadeem R Abu-Rustum; Richard R Barakat
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

2.  Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer.

Authors:  Jaeman Bae; Myong Cheol Lim; Jae-Ho Choi; Yong-Joong Song; Kyoung-Soo Lee; Sokbom Kang; Sang-Soo Seo; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

3.  Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery.

Authors:  Myong Cheol Lim; Hyun-Sung Lee; Dae Chul Jung; Ji Young Choi; Sang-Soo Seo; Sang-Yoon Park
Journal:  Ann Surg Oncol       Date:  2009-04-30       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.